This is a preprint.
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies
- PMID: 38077014
- PMCID: PMC10705596
- DOI: 10.21203/rs.3.rs-3659922/v1
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies
Update in
-
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies.Clin Proteomics. 2024 Apr 5;21(1):28. doi: 10.1186/s12014-024-09466-9. Clin Proteomics. 2024. PMID: 38580905 Free PMC article.
Abstract
Background: Certain demyelinating disorders, such as neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) exhibit serum autoantibodies against aquaporin-4 (αAQP4) and myelin oligodendrocyte glycoprotein (αMOG). The variability of the autoantibody presentation warrants further research into subtyping each case.
Methods: To elucidate the relationship between astroglial and neuronal protein concentrations in the peripheral circulation with occurrence of these autoantibodies, 86 serum samples were analyzed using immunoassays. The protein concentration of glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL) and tau protein was measured in 3 groups of subcategories of suspected NMOSD: αAQP4 positive (n = 20), αMOG positive (n = 32) and αMOG/αAQP4 seronegative (n = 34). Kruskal-Wallis analysis, univariate predictor analysis, and multivariate logistic regression with ROC curves were performed.
Results: GFAP and NFL concentrations were significantly elevated in the αAQP4 positive group (p = 0.003; p = 0.042, respectively), and tau was elevated in the αMOG/αAQP4 seronegative group (p < 0.001). A logistic regression model to classify serostatus was able to separate αAQP4 seropositivity using GFAP + tau, and αMOG seropositivity using tau. The areas under the ROC curves (AUCs) were 0.77 and 0.72, respectively. Finally, a combined seropositivity versus negative status logistic regression model was generated, with AUC = 0.80.
Conclusion: The 3 markers can univariately and multivariately classify with moderate accuracy the samples with seropositivity and seronegativity for αAQP4 and αMOG.
Keywords: Aquaporin 4; Myelin oligodendrocyte glycoprotein; autoantibody; autoimmunity; glial fibrillary acidic protein; neurofilament-light; tau.
Conflict of interest statement
Competing interests CD, RC, TG, MW, MS, AM, and GS are employees and JW is an officer of Meso Scale Diagnostics, LLC. Otherwise, the authors did not identify any potential, perceived or real conflicts of interest to disclose.
Figures
References
-
- Arciénega II, Brunet JF, Bloch J, Badaut J. Cell locations for AQP1, AQP4 and 9 in the non-human primate brain. Neuroscience. 2010. Jun 2;167(4):1103–14. - PubMed
-
- Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflammation. 2016. Sep 26;13:279. - PMC - PubMed
-
- Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet Lond Engl. 2004. Dec 11;364(9451):2106–12. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
